SciClone (SCLN +0.00%) results for the company's Q4 and 2012 have been released, following a delay due to restatement. For the quarter, net revenues were $33 million, down from the nearly $40 million in the same period the previous year. Non-GAAP net profit dropped more precipitously, to $2.0 million ($0.04 per diluted share) from Q4 2011's bottom line of $11.4 million ($0.19).
For fiscal 2012, net revenues were higher on a year-over-year basis. They totaled $156 million compared to the 2011 figure of $133 million. Net profit inched up to $36.7 million ($0.63 per diluted share) for the year against 2011's $34.0 million ($0.59).
SciClone also provided forward guidance. For full-year 2013, revenues are expected to come in at $150 million to $155 million and EPS should be $0.66 to $0.72.
